top of page

Full Projects

1. I CARE (Immunotherapy Cutaneous Adverse events REsearch)

PIs: Bao Vuong, PhD; Francesca Gany, MD, MS; Neil Shah, MBBS; Alina Markova, MD
Project Dates: 9/2024 – Present

Objectives:

  • Further identify biological factors associated with immune-related cutaneous adverse event development.

  • Identify associations between social influences of health and allostatic load with immune-related cutaneous adverse events and immune checkpoint inhibitor outcomes.

  • Conduct a randomized controlled trial to determine the impact of a side-effects navigation program compared with enhanced usual and customary care. 

2. Structural, chemical, and cellular probing of a new anticancer target: HIF-coactivator complexes

PIs: Kevin Gardner, PhD; Derek Tan, PhD
Project Dates: 9/2024 – Present

Objectives:

  • Determine the structural basis of HIF/coiled-coil coactivator interactions.

  • Use structural information to develop small-molecule HIF/CCC inhibitors.

  • Evaluate the cellular importance of HIF/coactivator interactions and the effects of the inhibitors on HIF-driven gene expression. 

Pilot Projects

3. Characterization of the role of RNA methylation in brain cancer progression

PIs: Jennifer Malin, PhD; Eric Lai, PhD
Project Dates: 9/2026 – Present

Objectives: To characterize how m6A RNA methylation regulators contribute to brain cancer progression and identify m6A-modified transcripts that may drive tumor growth in Drosophila models of glioma and medulloblastoma. 

4. GLOW (Get the LOwdown on alcohol and Wellness): A Pilot Randomized Controlled Trial

PIs: Wenhua Lu, PhD; Florence Lui, PhD
Project Dates: 9/2026 – Present

Objectives: To pilot a genetically and linguistically tailored brief alcohol literacy intervention to increase awareness of alcohol as a cancer risk factor and reduce harmful alcohol use; assess feasibility, acceptability, recruitment, retention, adherence, and preliminary changes in alcohol-related cancer knowledge and self-reported alcohol use. 

5. At the Intersection of Tumor, Immunity, and Muscle: Defining Early Molecular Events in Cancer Cachexia

 

PIs: Shuba Govind, PhD; Mary Baylies, PhD

Project Dates: 1/2027- Present

 

Objective: To identify the early molecular events that cause skeletal muscle wasting in cancer cachexia, using Drosophila models to study how tumor-derived signals and inflammation trigger muscle atrophy.

6. Multi Cancer Early Detection in Under Resourced Populations

PIs: Ronald Koder, PhD; Daniel Heller, PhD
Project Dates: 3/2026 – 2/2027

Objective:

  • Develop an AI-enabled, low-cost liquid biopsy platform using carbon nanotube optical nanosensors and machine learning to detect cancer from blood samples, initially focusing on non-small cell lung cancer with future expansion to multiple cancers. 

Pre-pilot Projects

1. Developing Asian GLOW (Get the LOwdown on alcohol and Wellness)

PIs: Wenhua Lu, PhD; Florence Lui, PhD
Project Dates: 9/2026 – 2/2027

Objectives: To develop an linguistically tailored, brief alcohol intervention adapted from an evidence-based alcohol literacy intervention to improve awareness of alcohol as a cancer risk factor. 

 

Previously Funded Projects

Pilot Projects

1. AI HEALS (HEalth Advances through Language Solutions)?

PIs: Jie Wei, PhD; Carlos Riobó, PhD; Francesca Gany, MD, MS; Javier González, MFA
Project Dates: 9/2024 – 8/2026

Objectives:

  • Compare the accuracy of three interpreting modalities: person-rendered consecutive interpreting, person-rendered remote simultaneous interpreting, and AI simultaneous medical interpreting.

  • Compare the efficiency of the interpreting modalities using audio recordings and the IHCD Efficiency Tool.

  • Assess the acceptability of AI simultaneous medical interpreting among patients and healthcare-system stakeholders. 

2. Comprehensive characterization of ancestry-associated immune features and response to immunotherapy

PIs: Sanna Goyert, PhD; Christopher Fong, PhD; Jian Carrot-Zhang, PhD
Project Dates: 9/2024 – 8/2026

Objectives:

  • Identify genetic variability and environmental factors associated with somatic mutations.

  • Investigate the relationship between smoking exposure and response to immunotherapy in patients. 

3. Digital Health Navigators for Spanish-Speaking Cancer Patients

PIs: Carlos Riobó, PhD; Lisa Diamond, MD, MPH
Project Dates: 1/2024 – 8/2025

Objectives:

  • Pilot the Digital Health Navigator intervention with 30 Spanish-speaking patients at the MSK Ralph Lauren Center and assess patient portal use and eHealth competence.

  • Evaluate the intervention using the RE-AIM QuEST framework through surveys, focus groups, and leadership interviews.

  • Assess DHN feedback on training, program recommendations, and career planning to inform a future randomized controlled trial.

Pre-Pilots

1. Adapting Single-Session Consultation for Cancer (SSC-C) to alleviate distress among breast cancer patients receiving immunotherapy

PIs: Adriana Espinosa, PhD; Devika Jutagir, PhD
Project Dates: 3/2025 – 12/2026

Objectives: 

  • Adapt Single-Session Consultation into SSC for Cancer through focus groups with 32 stakeholders.

  • Pre-pilot SSC-C with 20 breast cancer patients waitlisted for outpatient psychotherapy.

  • Assess self-efficacy, distress, and intervention feasibility, with the goal of improving self-efficacy and reducing distress. 

2. Bridging Gaps in Cancer Care: A mixed-methods approach to investigating cancer care impediments, facilitators, and outcomes

PIs: Larry Au, PhD; Joshua Budhu, MD
Project Dates: 3/2025 – 12/2026

Objectives:

  • Leverage existing databases and public resources to study emergency insurance coverage in New York State.

  • Conduct 30 interviews with Cancer Center Directors and clinicians to assess impediments, facilitators, and outcomes.

  • Combine quantitative database analysis with qualitative data collection from care providers. 

bottom of page